COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options

TJ Guzik, SA Mohiddin, A Dimarco, V Patel… - Cardiovascular …, 2020 - academic.oup.com
The novel coronavirus disease (COVID-19) outbreak, caused by SARS-CoV-2, represents
the greatest medical challenge in decades. We provide a comprehensive review of the …

Translating IL-6 biology into effective treatments

EH Choy, F De Benedetti, T Takeuchi… - Nature Reviews …, 2020 - nature.com
Abstract In 1973, IL-6 was identified as a soluble factor that is secreted by T cells and is
important for antibody production by B cells. Since its discovery more than 40 years ago, the …

Beyond the joints, the extra-articular manifestations in rheumatoid arthritis

A Conforti, I Di Cola, V Pavlych, P Ruscitti… - Autoimmunity …, 2021 - Elsevier
Rheumatoid arthritis (RA) is an inflammatory disease typically affecting the joints, but the
systemic inflammatory process may involve other tissues and organs. Many extra-articular …

Diagnosis and management of rheumatoid arthritis: a review

D Aletaha, JS Smolen - Jama, 2018 - jamanetwork.com
Importance Rheumatoid arthritis (RA) occurs in about 5 per 1000 people and can lead to
severe joint damage and disability. Significant progress has been made over the past 2 …

A general introduction to glucocorticoid biology

S Timmermans, J Souffriau, C Libert - Frontiers in immunology, 2019 - frontiersin.org
Glucocorticoids (GCs) are steroid hormones widely used for the treatment of inflammation,
autoimmune diseases, and cancer. To exert their broad physiological and therapeutic …

2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases

V Furer, C Rondaan, MW Heijstek… - Annals of the …, 2020 - ard.bmj.com
To update the European League Against Rheumatism (EULAR) recommendations for
vaccination in adult patients with autoimmune inflammatory rheumatic diseases (AIIRD) …

Targeting interleukin-6 signaling in clinic

S Kang, T Tanaka, M Narazaki, T Kishimoto - Immunity, 2019 - cell.com
Interleukin-6 (IL-6) is a pleiotropic cytokine with roles in immunity, tissue regeneration, and
metabolism. Rapid production of IL-6 contributes to host defense during infection and tissue …

Upadacitinib versus placebo or adalimumab in patients with rheumatoid arthritis and an inadequate response to methotrexate: results of a phase III, double‐blind …

R Fleischmann, AL Pangan, IH Song… - Arthritis & …, 2019 - Wiley Online Library
Objective To evaluate the efficacy, including capacity for inhibition of radiographic
progression, and safety of upadacitinib, a JAK 1‐selective inhibitor, as compared to placebo …

Methotrexate an old drug with new tricks

Y Bedoui, X Guillot, J Sélambarom, P Guiraud… - International journal of …, 2019 - mdpi.com
Methotrexate (MTX) is the first line drug for the treatment of a number of rheumatic and non-
rheumatic disorders. It is currently used as an anchor disease, modifying anti-rheumatic drug …

Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement

P Nash, A Kerschbaumer, T Dörner… - Annals of the …, 2021 - ard.bmj.com
Objectives Janus kinase inhibitors (JAKi) have been approved for use in various immune-
mediated inflammatory diseases. With five agents licensed, it was timely to summarise the …